Ignite Creation Date:
2024-05-05 @ 9:15 PM
Last Modification Date:
2024-10-26 @ 10:01 AM
Study NCT ID:
NCT00840931
Status:
COMPLETED
Last Update Posted:
2019-12-11
First Post:
2009-02-04
Brief Title:
Immunotherapy Using Lenalidomide Bystander Vaccine in High Risk Myelodysplastic Syndrome MDS
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Organization Data
Organization:
H Lee Moffitt Cancer Center and Research Institute
Class:
OTHER
Study ID:
MCC-14998
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene | INDUSTRY |